Read time: 5 minutes. This is Part 3 in our series on how drugs get approved to treat lung cancer. Part 1: Understanding Clinical Trials - Why Are They Important for Drug
Read time: 6 minutes. This is Part 2 of 3 in our series on how drugs get approved to treat lung cancer. Make sure to read Part 1 on the phases of clinical trials and why they are
Read time: 3 minutes. This is Part 1 in a 3-part series explaining how new drugs and treatments get approved to treat lung cancer. Parts 2 and 3 will be published in the coming
Read time: 3 minutes. Editors Note: If you missed the International Lung Cancer Survivorship Conference (ILCSC) on September 20-21, you can still register and watch recordings of
Read time: 2 minutes. Traditionally, people associate getting involved in lung cancer research with enrolling in a clinical trial. But most don’t realize they can also partner with
Read time: 4 minutes Lung cancer is often first identified as a nodule during a routine lung cancer screening or when someone is getting a chest scan for another reason, such as